ArticleActive
Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (L38168)
A57935
Wisconsin Physicians Service Insurance Corporation (J05)
Effective: March 15, 2020
Updated: December 31, 2025
See LCD L38168Policy Summary
This A57935 document is a response to comments regarding MolDX LCD L38168 (Guardant360 plasma-based comprehensive genomic profiling) and does not itself set coverage criteria. It directs providers to LCD L38168 for the definitive coverage policy; the LCD notice begins 2020-01-30 and becomes effective 2020-03-15.
Coverage Criteria Preview
Key requirements from the full policy
"This document is a response to public comments on MolDX LCD L38168 (Guardant360® plasma-based comprehensive genomic profiling in solid tumors); providers must refer to LCD L38168 for specific cover..."
Sign up to see full coverage criteria, indications, and limitations.